I am the youngest and feistiest writer and assistant editor for www.gurufocus.com. GuruFocus is a value investor's gold mine (or whatever you value)! We follow the world's best investors to gain insight into high growth and high valued companies.
I prefer diversified high risk, high reward investing. Biotechs are a current favorite. In 2014, up 34.5% (117 times the S&P), and Stocktwits is a big reason. Happy with the result, but still cautious.